TY - JOUR A1 - Chan, Lili A1 - Jaladanki, Suraj K. A1 - Somani, Sulaiman A1 - Paranjpe, Ishan A1 - Kumar, Arvind A1 - Zhao, Shan A1 - Kaufman, Lewis A1 - Leisman, Staci A1 - Sharma, Shuchita A1 - He, John Cijiang A1 - Murphy, Barbara A1 - Fayad, Zahi A. A1 - Levin, Matthew A. A1 - Böttinger, Erwin A1 - Charney, Alexander W. A1 - Glicksberg, Benjamin A1 - Coca, Steven G. A1 - Nadkarni, Girish N. T1 - Outcomes of patients on maintenance dialysis hospitalized with COVID-19 JF - Clinical journal of the American Society of Nephrology : CJASN KW - chronic dialysis KW - COVID-19 KW - end-stage kidney disease Y1 - 2021 U6 - https://doi.org/10.2215/CJN.12360720 SN - 1555-9041 SN - 1555-905X VL - 16 IS - 3 SP - 452 EP - 455 PB - American Society of Nephrology CY - Washington ER - TY - JOUR A1 - Chan, Lili A1 - Chaudhary, Kumardeep A1 - Saha, Aparna A1 - Chauhan, Kinsuk A1 - Vaid, Akhil A1 - Zhao, Shan A1 - Paranjpe, Ishan A1 - Somani, Sulaiman A1 - Richter, Felix A1 - Miotto, Riccardo A1 - Lala, Anuradha A1 - Kia, Arash A1 - Timsina, Prem A1 - Li, Li A1 - Freeman, Robert A1 - Chen, Rong A1 - Narula, Jagat A1 - Just, Allan C. A1 - Horowitz, Carol A1 - Fayad, Zahi A1 - Cordon-Cardo, Carlos A1 - Schadt, Eric A1 - Levin, Matthew A. A1 - Reich, David L. A1 - Fuster, Valentin A1 - Murphy, Barbara A1 - He, John C. A1 - Charney, Alexander W. A1 - Böttinger, Erwin A1 - Glicksberg, Benjamin A1 - Coca, Steven G. A1 - Nadkarni, Girish N. T1 - AKI in hospitalized patients with COVID-19 JF - Journal of the American Society of Nephrology : JASN N2 - Background: Early reports indicate that AKI is common among patients with coronavirus disease 2019 (COVID-19) and associatedwith worse outcomes. However, AKI among hospitalized patients with COVID19 in the United States is not well described. Methods: This retrospective, observational study involved a review of data from electronic health records of patients aged >= 18 years with laboratory-confirmed COVID-19 admitted to the Mount Sinai Health System from February 27 to May 30, 2020. We describe the frequency of AKI and dialysis requirement, AKI recovery, and adjusted odds ratios (aORs) with mortality. Results: Of 3993 hospitalized patients with COVID-19, AKI occurred in 1835 (46%) patients; 347 (19%) of the patientswith AKI required dialysis. The proportionswith stages 1, 2, or 3 AKIwere 39%, 19%, and 42%, respectively. A total of 976 (24%) patients were admitted to intensive care, and 745 (76%) experienced AKI. Of the 435 patients with AKI and urine studies, 84% had proteinuria, 81% had hematuria, and 60% had leukocyturia. Independent predictors of severe AKI were CKD, men, and higher serum potassium at admission. In-hospital mortality was 50% among patients with AKI versus 8% among those without AKI (aOR, 9.2; 95% confidence interval, 7.5 to 11.3). Of survivors with AKI who were discharged, 35% had not recovered to baseline kidney function by the time of discharge. An additional 28 of 77 (36%) patients who had not recovered kidney function at discharge did so on posthospital follow-up. Conclusions: AKI is common among patients hospitalized with COVID-19 and is associated with high mortality. Of all patients with AKI, only 30% survived with recovery of kidney function by the time of discharge. KW - acute renal failure KW - clinical nephrology KW - dialysis KW - COVID-19 Y1 - 2021 U6 - https://doi.org/10.1681/ASN.2020050615 SN - 1046-6673 SN - 1533-3450 VL - 32 IS - 1 SP - 151 EP - 160 PB - American Society of Nephrology CY - Washington ER - TY - JOUR A1 - Vaid, Akhil A1 - Chan, Lili A1 - Chaudhary, Kumardeep A1 - Jaladanki, Suraj K. A1 - Paranjpe, Ishan A1 - Russak, Adam J. A1 - Kia, Arash A1 - Timsina, Prem A1 - Levin, Matthew A. A1 - He, John Cijiang A1 - Böttinger, Erwin A1 - Charney, Alexander W. A1 - Fayad, Zahi A. A1 - Coca, Steven G. A1 - Glicksberg, Benjamin S. A1 - Nadkarni, Girish N. T1 - Predictive approaches for acute dialysis requirement and death in COVID-19 JF - Clinical journal of the American Society of Nephrology : CJASN N2 - Background and objectives AKI treated with dialysis initiation is a common complication of coronavirus disease 2019 (COVID-19) among hospitalized patients. However, dialysis supplies and personnel are often limited. Design, setting, participants, & measurements Using data from adult patients hospitalized with COVID-19 from five hospitals from theMount Sinai Health System who were admitted between March 10 and December 26, 2020, we developed and validated several models (logistic regression, Least Absolute Shrinkage and Selection Operator (LASSO), random forest, and eXtreme GradientBoosting [XGBoost; with and without imputation]) for predicting treatment with dialysis or death at various time horizons (1, 3, 5, and 7 days) after hospital admission. Patients admitted to theMount Sinai Hospital were used for internal validation, whereas the other hospitals formed part of the external validation cohort. Features included demographics, comorbidities, and laboratory and vital signs within 12 hours of hospital admission. Results A total of 6093 patients (2442 in training and 3651 in external validation) were included in the final cohort. Of the different modeling approaches used, XGBoost without imputation had the highest area under the receiver operating characteristic (AUROC) curve on internal validation (range of 0.93-0.98) and area under the precisionrecall curve (AUPRC; range of 0.78-0.82) for all time points. XGBoost without imputation also had the highest test parameters on external validation (AUROC range of 0.85-0.87, and AUPRC range of 0.27-0.54) across all time windows. XGBoost without imputation outperformed all models with higher precision and recall (mean difference in AUROC of 0.04; mean difference in AUPRC of 0.15). Features of creatinine, BUN, and red cell distribution width were major drivers of the model's prediction. Conclusions An XGBoost model without imputation for prediction of a composite outcome of either death or dialysis in patients positive for COVID-19 had the best performance, as compared with standard and other machine learning models. KW - COVID-19 KW - dialysis KW - machine learning KW - prediction KW - AKI Y1 - 2021 U6 - https://doi.org/10.2215/CJN.17311120 SN - 1555-9041 SN - 1555-905X VL - 16 IS - 8 SP - 1158 EP - 1168 PB - American Society of Nephrology CY - Washington ER - TY - JOUR A1 - Dellepiane, Sergio A1 - Vaid, Akhil A1 - Jaladanki, Suraj K. A1 - Coca, Steven A1 - Fayad, Zahi A. A1 - Charney, Alexander W. A1 - Böttinger, Erwin A1 - He, John Cijiang A1 - Glicksberg, Benjamin S. A1 - Chan, Lili A1 - Nadkarni, Girish T1 - Acute kidney injury in patients hospitalized with COVID-19 in New York City BT - Temporal Trends From March 2020 to April 2021 JF - Kidney medicine Y1 - 2021 U6 - https://doi.org/10.1016/j.xkme.2021.06.008 SN - 2590-0595 VL - 3 IS - 5 SP - 877 EP - 879 PB - Elsevier CY - Amsterdam ER -